Tyra Biosciences News - TYRA

Company Name	Stock Ticker Symbol	Market	Type
Tyra Biosciences Inc	TYRA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	17.35	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				17.35

more quote information »

Recent News

Date	Time	Source	Heading
5/09/2024	16:48	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
5/09/2024	16:46	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
5/09/2024	16:12	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/2024	16:08	EDGAR2	Form 8-K - Current report
5/09/2024	16:05	PRNUS	Tyra Biosciences Reports First Quarter 2024 Financial..
5/07/2024	16:34	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
5/07/2024	16:29	EDGAR2	Form 8-K - Current report
5/07/2024	16:05	PRNUS	Tyra Biosciences Announces Appointments of Susan Moran,..
3/19/2024	16:05	PRNUS	Tyra Biosciences Reports Fourth Quarter and Full Year 2023..
3/08/2024	17:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	17:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/29/2024	18:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/27/2024	16:05	PRNUS	Tyra Biosciences to Present at Upcoming Investor Conferences
2/14/2024	21:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/13/2024	16:36	EDGAR2	Form D - Notice of Exempt Offering of Securities
2/12/2024	16:46	EDGAR2	Form 144 - Report of proposed sale of securities
2/09/2024	19:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/07/2024	16:05	PRNUS	Tyra Biosciences to Present at Oppenheimer's 34th Annual..
2/06/2024	20:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/06/2024	16:56	EDGAR2	Form 144 - Report of proposed sale of securities
2/05/2024	06:05	EDGAR2	Form 8-K - Current report
2/02/2024	17:04	EDGAR2	Form 144 - Report of proposed sale of securities
2/02/2024	08:00	PRNUS	Tyra Biosciences, Inc. Announces $200 Million Private..
2/01/2024	17:30	PRNUS	Tyra Biosciences Receives FDA Rare Pediatric Disease..
2/01/2024	17:24	EDGAR2	Form 8-K - Current report
12/22/2023	09:00	EDGAR2	Form 8-K - Current report
12/22/2023	09:00	PRNUS	Tyra Biosciences Doses First Patient with TYRA-200 and..
11/08/2023	16:05	PRNUS	Tyra Biosciences to Participate in 2023 Jefferies London..
11/07/2023	16:16	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	16:07	EDGAR2	Form 8-K - Current report
11/07/2023	16:05	PRNUS	Tyra Biosciences Reports Third Quarter 2023 Financial..
10/26/2023	16:50	EDGAR2	Form 8-K - Current report
9/21/2023	08:00	PRNUS	Tyra Biosciences Announces Oral Presentations on TYRA-300..
9/19/2023	19:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/12/2023	16:05	PRNUS	Tyra Biosciences to Participate at 2023 Cantor Global..
8/10/2023	16:27	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	16:21	EDGAR2	Form 8-K - Current report
8/10/2023	16:05	PRNUS	Tyra Biosciences Reports Second Quarter 2023 Financial..
8/01/2023	17:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/01/2023	17:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/01/2023	08:54	DJN	Tyra Biosciences Gets FDA Orphan Designation for TYRA-300 in..
8/01/2023	08:00	PRNUS	Tyra Biosciences Announces FDA Orphan Drug Designation for..
7/21/2023	20:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/17/2023	19:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/12/2023	18:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/03/2023	17:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/28/2023	20:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
5/25/2023	08:00	PRNUS	Tyra Biosciences to Participate in Upcoming Investor..